Free shipping on all orders over $ 500

 About 1 result found for searched term "2367001-70-3" (0.119 seconds)

Cat.No.  Name Target
M25095 Grisnilimab Others
WT1
Grisnilimab (WT1), a IgG2a monoclonal antibody anti-CD7, is a tumor suppressor involved in the etiology of Wilms' tumor. Grisnilimab regulates the transcription of multiple target genes and may participate in the post-transcriptional processing of RNA.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.